In life there may be no second acts, but in life sciences management, there apparently are: Lewis Gruber, the formerly embattled CEO of Hyseq has just launched Arryx, a new Chicago-based venture that will manufacture bioarrays.
Japan has lately been making quite a show of its interest in the DNA biochip and microarray market. Every week or two reports of newly developed technologies appear, the government has launched two multi-year research projects, and the domestic microarray leader, Takara Shuzo, entered the global market earlier this year, becoming the first Japanese company to do so.
NGS-ArrayIt, a joint venture between Neo Gen Screening of Bridgeville, Pa. and TeleChem/ Arrayit.com, of Sunnyvale, Calif., has recently inked contracts to use microarrays to screen over a million newborn babies per year for genetic hearing loss disorders.
PerkinElmer, which agreed to acquire Packard Bioscience in a $650 million stock deal announced July 16, said it valued Packard s liquid handling and sample preparation capabilities but was also interested in using Packard s biochip instrumentation for protein chips.
MWG Biotech of Ebersberg, Germany, has launched RoboSmart, a new sample preparation lab robot that performs completely auto-mated plasmid or PCR product purification, including setting up, processing, and purifying the sequencing reac
On June 24, a day before Genometrix closed its doors, founder and chief executive officer Mitch Eggers resigned from the Woodlands, TX-based microarray services and gene expression software company to start a new genomics company.
AT A GLANCE Graduated in 1987 from Cardiff University, in Cardiff, Wales, UK, with a degree in biochemistry. Became technical support manager under Martin Evans and Peter Kille for the Cardiff University RNA Expression Center in April 2000.